A detailed history of Pathstone Holdings, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Pathstone Holdings, LLC holds 262,374 shares of ABT stock, worth $30.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
262,374
Previous 252,973 3.72%
Holding current value
$30.4 Million
Previous $26.3 Million 13.8%
% of portfolio
0.13%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$100.07 - $118.13 $940,758 - $1.11 Million
9,401 Added 3.72%
262,374 $29.9 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $219,087 - $244,557
2,175 Added 0.87%
252,973 $26.3 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $3.75 Million - $4.14 Million
34,198 Added 15.79%
250,798 $28.5 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $19.5 Million - $23.9 Million
216,600 New
216,600 $23.8 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.